Singapore legislation
Regulation 15
of Human Biomedical Research (Restricted Research) Regulations 2017
Regulation 15
Release of oocytes or embryos for research
Subregulation 1
Every researcher conducting or intending to conduct restricted research involving the use of oocytes or embryos must apply to the Director‑General, through his or her research institution, for approval for the relevant tissue bank (if any) to release oocytes or embryos or both.
Subregulation 2
Paragraph (1) does not apply to any immature oocyte or non‑viable embryo that is unsuitable for fertility treatment and would otherwise be discarded.
Subregulation 3
In determining whether to grant any approval for the release of oocytes or embryos or both, the Director‑General may consult the advisory committee established under section 5(2) of the Act.
Subregulation 4
The advisory committee established under section 5(2) of the Act must, in advising the Director‑General on whether to approve the release of oocytes or embryos or both —
review the scientific merit of the research proposal; and
consider the ethical issues and concerns with regard to conducting such a research at the wider societal level.